Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-24-000196
Filing Date
2024-02-12
Accepted
2024-02-12 17:34:08
Documents
1
Group Members
DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT HIF, L.P.DEERFIELD MGMT IV, L.P.DEERFIELD MGMT, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD PRIVATE DESIGN FUND IV, L.P.

Document Format Files

Seq Description Document Type Size
1 e619265_sc13ga-nuvalent.htm SC 13G/A 164969
  Complete submission text file 0001193805-24-000196.txt   166598
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A

Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Subject) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92743 | Film No.: 24621543
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)